Cargando…
Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer
BACKGROUND: Microsatellite has been proved to be an important prognostic factor and a treatment reference in colon cancer. The transcriptome profile and tumor microenvironment of different microsatellite statuses are different. Metastatic colon cancer patients with microsatellite instability-high (M...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008782/ https://www.ncbi.nlm.nih.gov/pubmed/35433823 http://dx.doi.org/10.3389/fsurg.2022.871823 |
_version_ | 1784687131598258176 |
---|---|
author | Luo, Rui Li, Yang Wu, Zhijie Zhang, Yuanxin Luo, Jian Yang, Keli Qin, Xiusen Wang, Huaiming Huang, Rongkang Wang, Hui Luo, Hongzhi |
author_facet | Luo, Rui Li, Yang Wu, Zhijie Zhang, Yuanxin Luo, Jian Yang, Keli Qin, Xiusen Wang, Huaiming Huang, Rongkang Wang, Hui Luo, Hongzhi |
author_sort | Luo, Rui |
collection | PubMed |
description | BACKGROUND: Microsatellite has been proved to be an important prognostic factor and a treatment reference in colon cancer. The transcriptome profile and tumor microenvironment of different microsatellite statuses are different. Metastatic colon cancer patients with microsatellite instability-high (MSI-H) are sensitive to immune checkpoint inhibitors (ICIs), but not fluorouracil. Efforts have been devoted to identify the predictive factors of immunotherapy. METHODS: We analyzed the transcriptome profile of different microsatellite statuses in colon cancer by using single-cell and bulk transcriptome data from publicly available databases. The immune cells in the tumor microenvironment were analyzed by the ESTIMATION algorithm. The microsatellite-related gene signature (MSRS) was constructed by the least absolute shrinkage and selection operator (LASSO) Cox regression based on the differentially expressed genes (DEGs) and its prognostic value and predictive value of response to immunotherapy were assessed. The prognostic value of the MSRS was also validated in another cohort. RESULTS: The MSI-H cancers cells were clustered differentially in the dimension reduction plot. Most of the immune cells have a higher proportion in the tumor immune microenvironment, except for CD56 bright natural killer cells. A total of 238 DEGs were identified. Based on the 238 DEGs, a neural network was constructed with a Kappa coefficient of 0.706 in the testing cohort. The MSRS is a favorable prognostic factor of overall survival, which was also validated in another cohort (GSE39582). Besides, MSRS is correlated with tumor mutation burden in MSI-H colon cancer. However, the MSRS is a barely satisfactory factor in predicting immunotherapy with the area under the curve (AUC) of 0.624. CONCLUSION: We developed the MSRS, which is a robust prognostic factor of overall survival in spite of a barely satisfactory immunotherapy predictor. Further studies may need to improve the predictive ability. |
format | Online Article Text |
id | pubmed-9008782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90087822022-04-15 Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer Luo, Rui Li, Yang Wu, Zhijie Zhang, Yuanxin Luo, Jian Yang, Keli Qin, Xiusen Wang, Huaiming Huang, Rongkang Wang, Hui Luo, Hongzhi Front Surg Surgery BACKGROUND: Microsatellite has been proved to be an important prognostic factor and a treatment reference in colon cancer. The transcriptome profile and tumor microenvironment of different microsatellite statuses are different. Metastatic colon cancer patients with microsatellite instability-high (MSI-H) are sensitive to immune checkpoint inhibitors (ICIs), but not fluorouracil. Efforts have been devoted to identify the predictive factors of immunotherapy. METHODS: We analyzed the transcriptome profile of different microsatellite statuses in colon cancer by using single-cell and bulk transcriptome data from publicly available databases. The immune cells in the tumor microenvironment were analyzed by the ESTIMATION algorithm. The microsatellite-related gene signature (MSRS) was constructed by the least absolute shrinkage and selection operator (LASSO) Cox regression based on the differentially expressed genes (DEGs) and its prognostic value and predictive value of response to immunotherapy were assessed. The prognostic value of the MSRS was also validated in another cohort. RESULTS: The MSI-H cancers cells were clustered differentially in the dimension reduction plot. Most of the immune cells have a higher proportion in the tumor immune microenvironment, except for CD56 bright natural killer cells. A total of 238 DEGs were identified. Based on the 238 DEGs, a neural network was constructed with a Kappa coefficient of 0.706 in the testing cohort. The MSRS is a favorable prognostic factor of overall survival, which was also validated in another cohort (GSE39582). Besides, MSRS is correlated with tumor mutation burden in MSI-H colon cancer. However, the MSRS is a barely satisfactory factor in predicting immunotherapy with the area under the curve (AUC) of 0.624. CONCLUSION: We developed the MSRS, which is a robust prognostic factor of overall survival in spite of a barely satisfactory immunotherapy predictor. Further studies may need to improve the predictive ability. Frontiers Media S.A. 2022-03-31 /pmc/articles/PMC9008782/ /pubmed/35433823 http://dx.doi.org/10.3389/fsurg.2022.871823 Text en Copyright © 2022 Luo, Li, Wu, Zhang, Luo, Yang, Qin, Wang, Huang, Wang and Luo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Surgery Luo, Rui Li, Yang Wu, Zhijie Zhang, Yuanxin Luo, Jian Yang, Keli Qin, Xiusen Wang, Huaiming Huang, Rongkang Wang, Hui Luo, Hongzhi Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer |
title | Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer |
title_full | Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer |
title_fullStr | Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer |
title_full_unstemmed | Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer |
title_short | Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer |
title_sort | comprehensive analysis of microsatellite-related transcriptomic signature and identify its clinical value in colon cancer |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008782/ https://www.ncbi.nlm.nih.gov/pubmed/35433823 http://dx.doi.org/10.3389/fsurg.2022.871823 |
work_keys_str_mv | AT luorui comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT liyang comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT wuzhijie comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT zhangyuanxin comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT luojian comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT yangkeli comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT qinxiusen comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT wanghuaiming comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT huangrongkang comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT wanghui comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer AT luohongzhi comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer |